Page 109 - CIBERER2016-ENG

Most relevant scientific articles
• Reyes-Palomares A., Bueno A., Rodriguez-Lopez R., Medina M., Sanchez-Jimenez F., Corpas M. et al. Systematic identification of phenotypically enriched loci using a patient network of genomic disorders. BMC Genomics. 2016;17(1).
• Garcia-Caballero M., Blacher S., Paupert J., Quesada A.R., Medina M.A., Noel A. Novel application assigned to toluquinol: Inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway. British Journal of Pharmacology. 2016.
• Bueno A., Morilla I., Diez D., Moya-Garcia A.A., Lozano J., Ranea J.A.G. Exploring the interactions of the RAS family in the human protein network and their potential implications in RAS-directed therapies. Oncotarget. 2016;7(46):75810-75826.
• Sanchez-Jimenez F., Pino-Angeles A., Rodriguez-Lopez R., Morales M., Urdiales J.L. Structural and functional analogies and differences between histidine decarboxylase and aromatic L-amino acid decarboxylase molecular networks: Biomedical implications. Pharmacological Research. 2016; 114:90-102.
• Rojano E., Ranea J.A., Perkins J.R.. Characterisation of non-coding genetic variation in histamine receptors using AnNCR-SNP. Amino Acids. 2016;48(10):2433-2442.
Hightlights
HUMAN CAPITAL
• in 2016 joined our group Dr. Aurelio Moya as a Post-Doc CIBERER Researcher. Graduates and M.D. Ma
Carmen Ocaña Farfán and Paloma Carrillo Fernández joined our group with a FPU Fellowship and with a contract associated to Grant P12-CTS-1507 (Plan Andaluz de Investigación), respectively.
SCIENTIFIC PRODUCTION
• In 2016, our group has published 15 scientific articles and 1 book chpater (García-Caballero M, Martínez-
Poveda B, Medina MA, Quesada AR. Targeting tumor angiogenesis for cancer prevention. In Molecular Targets and Strategies in Cancer Prevention (Chatterjee M, ed), pp 117-149, Springer 2016, ISBN 978-3- 319-31252-1).
• In 2016. CIBERER post-doctoral researcher Raúl Montañez published 5 articles. The synthetic biology approaches developed in one of these articles (Nucleic Acids Res 44, 496-507, 2016) are being adapted for the study of rare diseases.
• In 2016, our group has got a Spanish invention patent (ES2545929) and the entry into the regional phase of an international patent application (PCT/EP2014/064641).
ER
research groups 109